{
    "topic": "opioid_crisis",
    "source": "The Guardian",
    "bias": 0,
    "url": "https://www.theguardian.com/us-news/2019/oct/21/opioid-makers-drug-industry-trial-cleveland-ohio",
    "title": "Four big drug firms agree $260m opioid payout hours before trial set to begin",
    "date": "2019-10-21",
    "authors": "Chris Mcgreal",
    "content": "Four major pharmaceutical companies agreed to a multimillion-dollar payout over the US opioid epidemic on Monday , hours before a landmark federal trial in which they were facing accusations of a conspiracy to profit from addiction and death .\nWhy were millions of opioid pills sent to a West Virginia town of 3,000 ? Read more\nTeva Pharmaceuticals , the largest manufacturer of generic drugs in the world , and three drug distributors , among the biggest corporations in America , are to pay a total of $ 260m to settle the first of thousands of lawsuits by communities across the US which accuse the industry of creating an epidemic that that has claimed more than 400,000 lives over the past two decades .\nMonday \u2019 s trial in Ohio was intended to help establish whether opioid makers , drug distributors and pharmacy chains are liable to pay out billions to more than 2,700 cities , counties and Native American tribes .\nOther trials are scheduled in the coming months if a comprehensive deal involving all parties is not reached . Talks over a total payout of about $ 50bn stalled on Friday but lawyers said Monday \u2019 s settlement may provide a path to an agreement .\nThe Ohio lawsuit was brought by two counties , Cuyahoga and Summit , using anti-racketeering laws , originally written to go after organised crime . The counties claimed that manufacturers of narcotic painkillers aggressively drove up sales with knowingly false claims that they were less addictive and more effective than they were , leading to a huge surge in prescribing and addiction .\nThe question is how much is enough ? This is not enough . Armond Budish\nThey also alleged that distributors and pharmacies ignored legal obligations to restrict delivery and dispensing of the drugs , even as the death toll escalated , because they were making so much money .\nEileen Shapiro , the Summit county executive , said the lawsuit was intended to prevent drug companies flooding the area with opioids which \u201c devastated \u201d communities and created a surge in illegal opioids led by heroin and fentanyl .\n\u201c We started this originally to stop the behaviours , \u201d she said . \u201c Enough is enough . \u201d\nThe two counties were suing for a total of $ 7bn . Armond Budish , the Cuyahoga executive , said $ 260m would only go so far in dealing with the consequences of the epidemic .\n\u201c The question is how much is enough ? This is not enough , \u201d he said .\nBut he said it will provide some relief in offsetting the cost of treatment , the huge burden of overdoses on the emergency services and providing social care .\n\u201c Helping families deal with the results , \u201d he said . \u201c Helping kids basically left as orphans by this crisis . \u201d\nAmong the companies that agreed to payout on Monday were the distributors McKesson and AmerisourceBergen , both among the top 10 revenue-generating companies in the US . The Walgreens pharmacy chain did not settle . Its case will be joined with other pharmacies , including Walmart and CVS , at a separate trial .\nIn the weeks leading up to the trial several opioid makers reached settlements , including Johnson & Johnson which lost a major trial in Oklahoma in August when a judge found the company \u2019 s drive to sell opioids with false claims caused addiction and death .\nOpioid makers and distributors have paid out hundreds of millions of dollars to settle federal cases accusing them of failing to obey laws about cutting off opioid deliveries to pharmacies dispensing suspiciously large amounts of prescription painkillers . But the firms made no admission of liability .\nLawyers believe the industry is keen to avoid trials which will expose internal decision-making around the marketing , sale and delivery of opioids , and how much executives ignored evidence of rising addiction from prescription painkillers .\n\u201c We now know from discovery in this case how this industry worked , \u201d said one of the plaintiff \u2019 s attorneys , Joe Rice .\nRice and other lawyers say they will not permit drug companies to use settlements to prevent evidence of their responsibility for the epidemic from being made public . They say the release of documents will be a condition of any comprehensive agreement .\nThey \u2019 re getting away with murder . They \u2019 re buying their way out . They think that \u2019 s the way of doing business Emily Walden , Fed Up\nThat will be welcomed by activists who want to see the drug industry exposed .\nEmily Walden , chair of the Fed Up coalition of families and doctors , said she wants to see the prosecution of executives responsible for marketing and other strategies that boosted opioid sales .\n\u201c It \u2019 s pretty clear what happened and what they \u2019 ve done , \u201d she said . \u201c We need some accountability and it needs to lead to criminal charges . They \u2019 re getting away with murder . They \u2019 re buying their way out . They think that \u2019 s the way of doing business . \u201d\nWalden also said the proposed $ 50bn comprehensive settlement falls far short of what is needed . A new study has found that the epidemic has cost more than $ 800bn in the last four years . The Society of Actuaries said costs ranged from increased health and social care spending to loss of earnings by people who have died and pressure on the criminal justice system .\n\u201c We need hundreds of billions of dollars to deal with this crisis , \u201d said Walden . \u201c The settlement talks are not holding these companies accountable for what they \u2019 ve done . $ 50bn is pocket change to them . \u201d\nIn July federal prosecutors charged three top executives of the drug distributor Miami-Luken with illegally flooding parts of Appalachia with millions of opioid pills . In May , John Kapoor , the 75-year-old billionaire founder of Insys Therapeutics , was convicted for bribing doctors to prescribe a powerful opioid , Subsys , to patients who did not need it .\nPurdue Pharma , the maker of the powerful opioid OxyContin , which played a leading part in firing up the epidemic , is negotiating to end hundreds of lawsuits . The company has filed for bankruptcy as part of a proposed agreement that would see it put into a trust and future profits go toward alleviating the epidemic . Members of the Sackler family who own the company would also pay from the personal fortunes they have built from the sale of OxyContin .\nBut the deal is opposed by several state attorneys general who want to see the company out of business and the Sacklers , who are estimated to have made more than $ 12bn from opioids , pay more money .",
    "content_original": "Four major pharmaceutical companies agreed to a multimillion-dollar payout over the US opioid epidemic on Monday, hours before a landmark federal trial in which they were facing accusations of a conspiracy to profit from addiction and death.\n\nWhy were millions of opioid pills sent to a West Virginia town of 3,000? Read more\n\nTeva Pharmaceuticals, the largest manufacturer of generic drugs in the world, and three drug distributors, among the biggest corporations in America, are to pay a total of $260m to settle the first of thousands of lawsuits by communities across the US which accuse the industry of creating an epidemic that that has claimed more than 400,000 lives over the past two decades.\n\nMonday\u2019s trial in Ohio was intended to help establish whether opioid makers, drug distributors and pharmacy chains are liable to pay out billions to more than 2,700 cities, counties and Native American tribes.\n\nOther trials are scheduled in the coming months if a comprehensive deal involving all parties is not reached. Talks over a total payout of about $50bn stalled on Friday but lawyers said Monday\u2019s settlement may provide a path to an agreement.\n\nThe Ohio lawsuit was brought by two counties, Cuyahoga and Summit, using anti-racketeering laws, originally written to go after organised crime. The counties claimed that manufacturers of narcotic painkillers aggressively drove up sales with knowingly false claims that they were less addictive and more effective than they were, leading to a huge surge in prescribing and addiction.\n\nThe question is how much is enough? This is not enough. Armond Budish\n\nThey also alleged that distributors and pharmacies ignored legal obligations to restrict delivery and dispensing of the drugs, even as the death toll escalated, because they were making so much money.\n\nEileen Shapiro, the Summit county executive, said the lawsuit was intended to prevent drug companies flooding the area with opioids which \u201cdevastated\u201d communities and created a surge in illegal opioids led by heroin and fentanyl.\n\n\u201cWe started this originally to stop the behaviours,\u201d she said. \u201cEnough is enough.\u201d\n\nThe two counties were suing for a total of $7bn. Armond Budish, the Cuyahoga executive, said $260m would only go so far in dealing with the consequences of the epidemic.\n\n\u201cThe question is how much is enough? This is not enough,\u201d he said.\n\nBut he said it will provide some relief in offsetting the cost of treatment, the huge burden of overdoses on the emergency services and providing social care.\n\n\u201cHelping families deal with the results,\u201d he said. \u201cHelping kids basically left as orphans by this crisis.\u201d\n\nAmong the companies that agreed to payout on Monday were the distributors McKesson and AmerisourceBergen, both among the top 10 revenue-generating companies in the US. The Walgreens pharmacy chain did not settle. Its case will be joined with other pharmacies, including Walmart and CVS, at a separate trial.\n\nIn the weeks leading up to the trial several opioid makers reached settlements, including Johnson & Johnson which lost a major trial in Oklahoma in August when a judge found the company\u2019s drive to sell opioids with false claims caused addiction and death.\n\nOpioid makers and distributors have paid out hundreds of millions of dollars to settle federal cases accusing them of failing to obey laws about cutting off opioid deliveries to pharmacies dispensing suspiciously large amounts of prescription painkillers. But the firms made no admission of liability.\n\nLawyers believe the industry is keen to avoid trials which will expose internal decision-making around the marketing, sale and delivery of opioids, and how much executives ignored evidence of rising addiction from prescription painkillers.\n\n\u201cWe now know from discovery in this case how this industry worked,\u201d said one of the plaintiff\u2019s attorneys, Joe Rice.\n\nRice and other lawyers say they will not permit drug companies to use settlements to prevent evidence of their responsibility for the epidemic from being made public. They say the release of documents will be a condition of any comprehensive agreement.\n\nThey\u2019re getting away with murder. They\u2019re buying their way out. They think that\u2019s the way of doing business Emily Walden, Fed Up\n\nThat will be welcomed by activists who want to see the drug industry exposed.\n\nEmily Walden, chair of the Fed Up coalition of families and doctors, said she wants to see the prosecution of executives responsible for marketing and other strategies that boosted opioid sales.\n\n\u201cIt\u2019s pretty clear what happened and what they\u2019ve done,\u201d she said. \u201cWe need some accountability and it needs to lead to criminal charges. They\u2019re getting away with murder. They\u2019re buying their way out. They think that\u2019s the way of doing business.\u201d\n\nWalden also said the proposed $50bn comprehensive settlement falls far short of what is needed. A new study has found that the epidemic has cost more than $800bn in the last four years. The Society of Actuaries said costs ranged from increased health and social care spending to loss of earnings by people who have died and pressure on the criminal justice system.\n\n\u201cWe need hundreds of billions of dollars to deal with this crisis,\u201d said Walden. \u201cThe settlement talks are not holding these companies accountable for what they\u2019ve done. $50bn is pocket change to them.\u201d\n\nThere have been some criminal prosecutions.\n\nIn July federal prosecutors charged three top executives of the drug distributor Miami-Luken with illegally flooding parts of Appalachia with millions of opioid pills. In May, John Kapoor, the 75-year-old billionaire founder of Insys Therapeutics, was convicted for bribing doctors to prescribe a powerful opioid, Subsys, to patients who did not need it.\n\nPurdue Pharma, the maker of the powerful opioid OxyContin, which played a leading part in firing up the epidemic, is negotiating to end hundreds of lawsuits. The company has filed for bankruptcy as part of a proposed agreement that would see it put into a trust and future profits go toward alleviating the epidemic. Members of the Sackler family who own the company would also pay from the personal fortunes they have built from the sale of OxyContin.\n\nBut the deal is opposed by several state attorneys general who want to see the company out of business and the Sacklers, who are estimated to have made more than $12bn from opioids, pay more money.",
    "source_url": "www.theguardian.com",
    "bias_text": "left",
    "ID": "8JqHJKtbvKibRljH"
}